Does a human rights-based approach to harm reduction support commercialized harm reduction? Brief research

Area of Science:

• Public Health
• Human Rights Law
• Tobacco Control Policy

Background:

• The tobacco industry promotes newer products like e-cigarettes as socially responsible, potentially reduced-harm alternatives.
• This commercialized harm reduction strategy is questioned for its alignment with public health principles and the right to health.

Approach:

• Analyzed tobacco industry materials from 2017-2022 focusing on harm reduction narratives.
• Applied a human rights-based approach (HRBA) to evaluate the industry's commercialized harm reduction claims.
• Examined the compatibility of industry practices with core harm reduction principles and the right to health.

Key Points:

• Industry marketing of combustible and "potentially less harmful" products simultaneously dilutes harm reduction principles.
• Industry advocacy for less stringent regulation of non-combustible products undermines public health goals.
• Commercialized tobacco harm reduction, as practiced by the industry, conflicts with the human right to health.

Conclusions:

• The tobacco industry's commercialized approach to harm reduction is fundamentally incompatible with a human rights-based framework.
• A human rights-based approach necessitates prioritizing public health and the right to health over commercial interests in tobacco control.